<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR9">
 <label>9.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Pipas</surname>
    <given-names>JM</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma</article-title>
  <source>Ann Oncol</source>
  <year>2012</year>
  <volume>23</volume>
  <fpage>2820</fpage>
  <lpage>2827</lpage>
  <pub-id pub-id-type="doi">10.1093/annonc/mds109</pub-id>
  <?supplied-pmid 22571859?>
  <pub-id pub-id-type="pmid">22571859</pub-id>
 </element-citation>
</ref>
